Diagnostic approach to myelodysplastic syndromes

Shanxiang Zhang, Jiehao Zhou, Mehdi Nassiri, Magdalena Czader

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Myelodysplastic syndromes (MDS) are heterogeneous hematopoietic stem cell neoplasms manifesting as cytopenia(s), morphologic dysplasia, functional abnormalities of hematopoietic lineages and a propensity to progress to acute myeloid leukemia. MDS is relatively common, particularly in the elderly population. In this chapter, we describe an integrated approach to a diagnosis of MDS. Relevant clinical history and specimens required for a complete diagnostic work-up are discussed. The key morphologic features including blasts and dysplasia seen in hematopoietic populations are described in detail. The contribution of flow cytometric immunophenotyping and cytogenetics/genetics to the routine diagnosis and the prediction of prognosis are discussed. Finally, the current 2008 WHO classification of MDS including the salient diagnostic features and major differential diagnoses are reviewed. Rare MDS types associated with unique morphology (MDS with fibrosis, hypoplastic MDS and erythroid-predominant MDS) are also presented.

Original languageEnglish
Title of host publicationMyelodysplastic Syndromes: From Pathogenesis to Diagnosis and Therapy
PublisherNova Science Publishers, Inc.
Pages25-60
Number of pages36
ISBN (Print)9781624175749
StatePublished - Jan 2013

Fingerprint

Myelodysplastic Syndromes
Immunophenotyping
Hematopoietic Stem Cells
Acute Myeloid Leukemia
Cytogenetics
Population
Differential Diagnosis
Fibrosis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Zhang, S., Zhou, J., Nassiri, M., & Czader, M. (2013). Diagnostic approach to myelodysplastic syndromes. In Myelodysplastic Syndromes: From Pathogenesis to Diagnosis and Therapy (pp. 25-60). Nova Science Publishers, Inc..

Diagnostic approach to myelodysplastic syndromes. / Zhang, Shanxiang; Zhou, Jiehao; Nassiri, Mehdi; Czader, Magdalena.

Myelodysplastic Syndromes: From Pathogenesis to Diagnosis and Therapy. Nova Science Publishers, Inc., 2013. p. 25-60.

Research output: Chapter in Book/Report/Conference proceedingChapter

Zhang, S, Zhou, J, Nassiri, M & Czader, M 2013, Diagnostic approach to myelodysplastic syndromes. in Myelodysplastic Syndromes: From Pathogenesis to Diagnosis and Therapy. Nova Science Publishers, Inc., pp. 25-60.
Zhang S, Zhou J, Nassiri M, Czader M. Diagnostic approach to myelodysplastic syndromes. In Myelodysplastic Syndromes: From Pathogenesis to Diagnosis and Therapy. Nova Science Publishers, Inc. 2013. p. 25-60
Zhang, Shanxiang ; Zhou, Jiehao ; Nassiri, Mehdi ; Czader, Magdalena. / Diagnostic approach to myelodysplastic syndromes. Myelodysplastic Syndromes: From Pathogenesis to Diagnosis and Therapy. Nova Science Publishers, Inc., 2013. pp. 25-60
@inbook{58999a1b50fa40d88142823d58ae5fa7,
title = "Diagnostic approach to myelodysplastic syndromes",
abstract = "Myelodysplastic syndromes (MDS) are heterogeneous hematopoietic stem cell neoplasms manifesting as cytopenia(s), morphologic dysplasia, functional abnormalities of hematopoietic lineages and a propensity to progress to acute myeloid leukemia. MDS is relatively common, particularly in the elderly population. In this chapter, we describe an integrated approach to a diagnosis of MDS. Relevant clinical history and specimens required for a complete diagnostic work-up are discussed. The key morphologic features including blasts and dysplasia seen in hematopoietic populations are described in detail. The contribution of flow cytometric immunophenotyping and cytogenetics/genetics to the routine diagnosis and the prediction of prognosis are discussed. Finally, the current 2008 WHO classification of MDS including the salient diagnostic features and major differential diagnoses are reviewed. Rare MDS types associated with unique morphology (MDS with fibrosis, hypoplastic MDS and erythroid-predominant MDS) are also presented.",
author = "Shanxiang Zhang and Jiehao Zhou and Mehdi Nassiri and Magdalena Czader",
year = "2013",
month = "1",
language = "English",
isbn = "9781624175749",
pages = "25--60",
booktitle = "Myelodysplastic Syndromes: From Pathogenesis to Diagnosis and Therapy",
publisher = "Nova Science Publishers, Inc.",

}

TY - CHAP

T1 - Diagnostic approach to myelodysplastic syndromes

AU - Zhang, Shanxiang

AU - Zhou, Jiehao

AU - Nassiri, Mehdi

AU - Czader, Magdalena

PY - 2013/1

Y1 - 2013/1

N2 - Myelodysplastic syndromes (MDS) are heterogeneous hematopoietic stem cell neoplasms manifesting as cytopenia(s), morphologic dysplasia, functional abnormalities of hematopoietic lineages and a propensity to progress to acute myeloid leukemia. MDS is relatively common, particularly in the elderly population. In this chapter, we describe an integrated approach to a diagnosis of MDS. Relevant clinical history and specimens required for a complete diagnostic work-up are discussed. The key morphologic features including blasts and dysplasia seen in hematopoietic populations are described in detail. The contribution of flow cytometric immunophenotyping and cytogenetics/genetics to the routine diagnosis and the prediction of prognosis are discussed. Finally, the current 2008 WHO classification of MDS including the salient diagnostic features and major differential diagnoses are reviewed. Rare MDS types associated with unique morphology (MDS with fibrosis, hypoplastic MDS and erythroid-predominant MDS) are also presented.

AB - Myelodysplastic syndromes (MDS) are heterogeneous hematopoietic stem cell neoplasms manifesting as cytopenia(s), morphologic dysplasia, functional abnormalities of hematopoietic lineages and a propensity to progress to acute myeloid leukemia. MDS is relatively common, particularly in the elderly population. In this chapter, we describe an integrated approach to a diagnosis of MDS. Relevant clinical history and specimens required for a complete diagnostic work-up are discussed. The key morphologic features including blasts and dysplasia seen in hematopoietic populations are described in detail. The contribution of flow cytometric immunophenotyping and cytogenetics/genetics to the routine diagnosis and the prediction of prognosis are discussed. Finally, the current 2008 WHO classification of MDS including the salient diagnostic features and major differential diagnoses are reviewed. Rare MDS types associated with unique morphology (MDS with fibrosis, hypoplastic MDS and erythroid-predominant MDS) are also presented.

UR - http://www.scopus.com/inward/record.url?scp=84895397416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895397416&partnerID=8YFLogxK

M3 - Chapter

SN - 9781624175749

SP - 25

EP - 60

BT - Myelodysplastic Syndromes: From Pathogenesis to Diagnosis and Therapy

PB - Nova Science Publishers, Inc.

ER -